(Q51217303)

English

The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/3082644

The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects. (English)

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/3082644

human subject research project

0 references

1 reference

based on heuristic

inferred from title

author name string

H V Curran

1

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/3082644

M Lader

2

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/3082644

publication date

1 January 1986

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/3082644

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/3082644

29

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/3082644

601-607

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/3082644

5

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/3082644

https://scigraph.springernature.com/pub.10.1007/bf00635900

0 references

Physiological and psychological effects of clorazepate in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind controlled clinical trial comparing fluvoxamine with imipramine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluvoxamine?A new serotonin re-uptake inhibitor: First clinical and psychometric experiences in depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind placebo-controlled study to compare the autonomic effects of fluvoxamine with those of amitriptyline and doxepin in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/3082644

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00635900

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/3082644

1 reference

Europe PubMed Central

1 April 2018

http://europepmc.org/abstract/MED/3082644

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51217303&oldid=1381392517"